Last reviewed · How we verify
NCT03515460
Acute Effects of Oral Carbohydrate and Fat Loads on Systemic Microvascular Endothelial Function in Healthy Individuals.
NA trial testing sugar oral load in Metabolic Syndrome in 60 participants. Completed in 20 December 2023.
1 December 2023
Quick facts
| Lead sponsor | National Institute of Cardiology, Laranjeiras, Brazil |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 60 |
| Start date | 10 December 2018 |
| Primary completion | 1 December 2023 |
| Estimated completion | 20 December 2023 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- sugar oral load
- fat oral load
- sugar and fat oral load
Conditions studied
- Metabolic Syndrome — all drugs for Metabolic Syndrome →
Sponsor
National Institute of Cardiology, Laranjeiras, Brazil
Who can join
Adults 20 to 30, any sex, with Metabolic Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The present study was designed to evaluate vascular endothelial dysfunction resulting from the oral ingestion of high loads of sugar and fat meals in healthy individuals.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03515460
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Metabolic Syndrome
Currently open trials in the same condition.
- NCT07501858 — Assessing the Association Between H. Pylori Persistence and the Severity of Insulin Resistance in Patients With Metaboli · recruiting
- NCT06857929 — "Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition" · NA · recruiting
- NCT07237750 — iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss · NA · recruiting
- NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors · NA · recruiting
- NCT07383220 — Effect of Electrical Stimulation and Exercise on Blood Flow in Patients With Resistant High Blood Pressure · NA · recruiting
Other National Institute of Cardiology, Laranjeiras, Brazil trials
Trials by the same sponsor.
- NCT05728047 — Evaluation of Systemic Microcirculation of Patients Undergoing Heart Valve Surgery · completed
- NCT04946396 — Effects of Continuous Dexmedetomidine Infusion on Systemic Microvascular Function in Laparoscopic Cholecystecthomy · NA · completed
- NCT05464849 — Evaluation of Systemic Microvascular Reactivity in Patients With Resistant Hypertension · completed
- NCT05864729 — The Association Between Systemic Microvascular Endothelial Function and Coronary Physiology Indexes · NA · completed
- NCT04406545 — Microvascular Flow and Reactivity in Patients Presenting in the Acute Phase of COVID-19. · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03515460 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Institute of Cardiology, Laranjeiras, Brazil
- Last refreshed: 26 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03515460.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing